WHO vaccine-preventable diseases: monitoring system. 2016 global summary

Last updated 27-May-2016 (Data received as of 20-May-2016)
Next overall update Fall 2016
2015 data are provisionary
EPI mother and child logo         
Select a country

Development status: Economy in transition GNI / capita (US$): 3'8101 Infant (under 12 months) mortality rate: 132
GDP / capita (US$): 8'1381 Child (under 5 years) mortality rate: 142

Population data in thousands3

  2015  2014  2013  2012  2011  2000  1990  1980 
Total population 3'018  3'006  2'992  2'978  2'968  3'076  3'545  3'096 
Births 39  39  40  40  41  41  74  69 
Surviving infants 39  39  39  40  40  39  71  66 
Pop. less than 5 years 207  210  213  214  215  197  389  331 
Pop. less than 15 years 555  561  569  579  592  795  1'077  941 
Female 15-49 years 805  801  792  780  769  862  900  837 

Number of reported cases

(Click for retrospective incidence data for Armenia)
Diphtheria
ChartChart
 
Japanese encephalitis
ChartChart
 
Measles
ChartChart
  33  13  10  15  879 
Mumps
ChartChart
  15  3'431 
Pertussis
ChartChart
  27  85  30  10  469 
Polio*
ChartChart
 
Rubella
ChartChart
  673 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
ChartChart
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Armenia)
Vaccine year result method % card seen                                                
BCG 2009  100  DHS   92  99  99  99  96  96  97 
DTP1 2009  99  DHS   92  97  97  97  98  98 
DTP3 2009  95  DHS   92  94  93  95  95  95  93 
DTP4          94  93 
IPV1         
HepB_BD          98  98  98  95  95  97 
HepB3 2009  90  DHS   92  94  93  95  95  95  55 
Hib3          94  93  95  95  98 
JapEnc         
MCV1          97  97  97  97  97  92 
MCV2          97  97  97  97  98  94 
PCV1          45 
PCV3          44 
Pol3 2009  95  DHS   92  96  95  96  96  96  96 
Rota1          95  94  92 
RotaC          93  91  90 
Rubella1          97  97  97  97 
TT2plus         
PAB         
VAD1         
YFV         
° indicates that more than 1 survey occurred that year.  * indicates the country reported above 100% coverage.

  Next update: Mid July 2016

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Armenia)
BCG
ChartChart
  99  99  96  96  97 
DTP1
ChartChart
  97  97  98  98  97 
DTP3
ChartChart
  93  95  95  95  93 
HepB3
ChartChart
  93  95  95  95  55 
HepB_BD
ChartChart
  98  98  95  95  97 
Hib3
ChartChart
  93  95  95  95 
MCV1
ChartChart
  97  97  97  97  92 
MCV2
ChartChart
  97  97  97  98  94 
PCV3
ChartChart
 
Pol3
ChartChart
  95  96  96  96  96 
RotaC
ChartChart
  91  33 

Number of districts in the country 48  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 90
From 80 to 89% 10
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2015 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 12, 18 weeks; Yes
HepA 15 years; Yes
HepB_Pediatric birth; Yes
Influenza_Adult Yes elderly and adults with chronic illness, health care workers, pregnanct women, and other risk groups
Influenza_Pediatric Yes and children with chronic illness
MMR 1, 6, 15 years; Yes
MenACWY 15 years; Yes
OPV 6, 12, 18 weeks; 18 months; 6 years; Yes
Pneumo_conj 6, 12, 18 weeks; Yes
Pneumo_ps 15 years; Yes
Rotavirus 6, 12 weeks; Yes
Td 6, 15-16, 26-30, 36-40, 46-50, 56-60 years; Yes

Immunizaton indicators

Indicator Expected answer 2015  2014  2013  2012  2011  2010  2009 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2010-2015  2010-2015  2010-2015  2010-2015  2010-2015  2007-2010   
Nº of districts with microplans that include activities to raise immunization coverage number       51  51  51   

System performance

Total Nº districts in country number 51  51  51  51  51  51  51 
Nº districts with DTP3 coverage >=80% number 51  51  51  51  51  50  48 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  100  100  100  100  98  94 
Nº districts with measles (MCV1) coverage >=95% number 44  47  47  48  46  42  30 
% of districts with MCV1 coverage >=95% From 0 to 100% 86  92  92  94  90  82  59 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND Yes  Yes  Yes  Yes  Yes     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 99    65  75  66  63   

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  Yes  Yes  Yes  Yes     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2015 revision". New York, 2016.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.